180 related articles for article (PubMed ID: 24828426)
1. Impact of response shift on time to deterioration in quality of life scores in breast cancer patients.
Hamidou Z; Dabakuyo-Yonli TS; Guillemin F; Conroy T; Velten M; Jolly D; Causeret S; Graesslin O; Gauthier M; Mercier M; Bonnetain F
PLoS One; 2014; 9(5):e96848. PubMed ID: 24828426
[TBL] [Abstract][Full Text] [Related]
2. Time to deterioration in quality of life score as a modality of longitudinal analysis in patients with breast cancer.
Hamidou Z; Dabakuyo TS; Mercier M; Fraisse J; Causeret S; Tixier H; Padeano MM; Loustalot C; Cuisenier J; Sauzedde JM; Smail M; Combier JP; Chevillote P; Rosburger C; Arveux P; Bonnetain F
Oncologist; 2011; 16(10):1458-68. PubMed ID: 21948650
[TBL] [Abstract][Full Text] [Related]
3. Impact of the occurrence of a response shift on the determination of the minimal important difference in a health-related quality of life score over time.
Ousmen A; Conroy T; Guillemin F; Velten M; Jolly D; Mercier M; Causeret S; Cuisenier J; Graesslin O; Hamidou Z; Bonnetain F; Anota A
Health Qual Life Outcomes; 2016 Dec; 14(1):167. PubMed ID: 27914467
[TBL] [Abstract][Full Text] [Related]
4. Minimal clinically important differences in the EORTC QLQ-C30 and brief pain inventory in patients undergoing re-irradiation for painful bone metastases.
Raman S; Ding K; Chow E; Meyer RM; van der Linden YM; Roos D; Hartsell WF; Hoskin P; Wu JSY; Nabid A; Haas R; Wiggenraad R; Babington S; Demas WF; Wilson CF; Wong RKS; Zhu L; Brundage M
Qual Life Res; 2018 Apr; 27(4):1089-1098. PubMed ID: 29188483
[TBL] [Abstract][Full Text] [Related]
5. Longitudinal analysis of quality of life in primary lung cancer patients with chlamydia pneumoniae infection: a time-to-deterioration model.
Chen Z; Zhuang J; Liu M; Xu X; Liu Y; Yang S; Xie J; Lin N; Lai F; He F
BMC Pulm Med; 2024 Jan; 24(1):36. PubMed ID: 38233781
[TBL] [Abstract][Full Text] [Related]
6. Response shift effects on measuring post-operative quality of life among breast cancer patients: a multicenter cohort study.
Dabakuyo TS; Guillemin F; Conroy T; Velten M; Jolly D; Mercier M; Causeret S; Cuisenier J; Graesslin O; Gauthier M; Bonnetain F
Qual Life Res; 2013 Feb; 22(1):1-11. PubMed ID: 22383104
[TBL] [Abstract][Full Text] [Related]
7. Quality of life with talazoparib versus physician's choice of chemotherapy in patients with advanced breast cancer and germline BRCA1/2 mutation: patient-reported outcomes from the EMBRACA phase III trial.
Ettl J; Quek RGW; Lee KH; Rugo HS; Hurvitz S; Gonçalves A; Fehrenbacher L; Yerushalmi R; Mina LA; Martin M; Roché H; Im YH; Markova D; Bhattacharyya H; Hannah AL; Eiermann W; Blum JL; Litton JK
Ann Oncol; 2018 Sep; 29(9):1939-1947. PubMed ID: 30124753
[TBL] [Abstract][Full Text] [Related]
8. Longitudinal change of quality of life in the first five years of survival among disease-free Chinese breast cancer survivors.
Lei YY; Ho SC; Lau TKH; Kwok C; Cheng A; Cheung KL; Lee R; Yeo W
Qual Life Res; 2021 Jun; 30(6):1583-1594. PubMed ID: 33447955
[TBL] [Abstract][Full Text] [Related]
9. Patient self-appraisal of change and minimal clinically important difference on the European organization for the research and treatment of cancer quality of life questionnaire core 30 before and during cancer therapy.
Hong F; Bosco JL; Bush N; Berry DL
BMC Cancer; 2013 Mar; 13():165. PubMed ID: 23537330
[TBL] [Abstract][Full Text] [Related]
10. Health-related Quality of Life in the Phase III LUME-Colon 1 Study: Comparison and Interpretation of Results From EORTC QLQ-C30 Analyses.
Lenz HJ; Argiles G; Yoshino T; Lonardi S; Falcone A; Limón ML; Sobrero A; Hastedt C; Peil B; Voss F; Griebsch I; Van Cutsem E
Clin Colorectal Cancer; 2019 Dec; 18(4):269-279.e5. PubMed ID: 31628043
[TBL] [Abstract][Full Text] [Related]
11. Association between physical activity and health-related quality of life: time to deterioration model analysis in lung adenocarcinoma.
Zhuang J; Liu Y; Xu X; Cai Y; Liu M; Chen Z; Yang S; Lin J; Hu Z; Kang M; Lin M; He F
J Cancer Surviv; 2023 Dec; 17(6):1769-1779. PubMed ID: 36192668
[TBL] [Abstract][Full Text] [Related]
12. Item response theory and factor analysis as a mean to characterize occurrence of response shift in a longitudinal quality of life study in breast cancer patients.
Anota A; Bascoul-Mollevi C; Conroy T; Guillemin F; Velten M; Jolly D; Mercier M; Causeret S; Cuisenier J; Graesslin O; Hamidou Z; Bonnetain F
Health Qual Life Outcomes; 2014 Mar; 12():32. PubMed ID: 24606836
[TBL] [Abstract][Full Text] [Related]
13. Ribociclib plus fulvestrant for advanced breast cancer: Health-related quality-of-life analyses from the MONALEESA-3 study.
Fasching PA; Beck JT; Chan A; De Laurentiis M; Esteva FJ; Jerusalem G; Neven P; Pivot X; Bianchi GV; Martin M; Chandiwana D; Lanoue B; Ridolfi A; Wang Y; Rodriguez Lorenc K; Nusch A
Breast; 2020 Dec; 54():148-154. PubMed ID: 33065342
[TBL] [Abstract][Full Text] [Related]
14. Assessment of quality of life (QoL) in breast cancer patients by using EORTC QLQ-C30 and BR-23 questionnaires: A tertiary care center survey in the western region of Saudi Arabia.
Imran M; Al-Wassia R; Alkhayyat SS; Baig M; Al-Saati BA
PLoS One; 2019; 14(7):e0219093. PubMed ID: 31291302
[TBL] [Abstract][Full Text] [Related]
15. Predictors of the course of quality of life during therapy in women with primary breast cancer.
Wöckel A; Schwentner L; Krockenberger M; Kreienberg R; Janni W; Wischnewsky M; Thorsten K; Felix F; Riccardo F; Blettner M; Singer S
Qual Life Res; 2017 Aug; 26(8):2201-2208. PubMed ID: 28386772
[TBL] [Abstract][Full Text] [Related]
16. Health - related quality of life of Kuwaiti women with breast cancer: a comparative study using the EORTC Quality of Life Questionnaire.
Alawadi SA; Ohaeri JU
BMC Cancer; 2009 Jul; 9():222. PubMed ID: 19586536
[TBL] [Abstract][Full Text] [Related]
17. Health-Related Quality of Life in Patients With Progressive Midgut Neuroendocrine Tumors Treated With
Strosberg J; Wolin E; Chasen B; Kulke M; Bushnell D; Caplin M; Baum RP; Kunz P; Hobday T; Hendifar A; Oberg K; Sierra ML; Thevenet T; Margalet I; Ruszniewski P; Krenning E;
J Clin Oncol; 2018 Sep; 36(25):2578-2584. PubMed ID: 29878866
[TBL] [Abstract][Full Text] [Related]
18. Quality of life of Croatian breast cancer patients receiving adjuvant treatment--comparison to long-term breast cancer survivors.
Murgić J; Soldić Z; Vrljić D; Samija I; Kirac I; Bolanca A; Kusić Z
Coll Antropol; 2012 Dec; 36(4):1335-41. PubMed ID: 23390830
[TBL] [Abstract][Full Text] [Related]
19. Differential impact of endocrine therapy and chemotherapy on quality of life of breast cancer survivors: a prospective patient-reported outcomes analysis.
Ferreira AR; Di Meglio A; Pistilli B; Gbenou AS; El-Mouhebb M; Dauchy S; Charles C; Joly F; Everhard S; Lambertini M; Coutant C; Cottu P; Lerebours F; Petit T; Dalenc F; Rouanet P; Arnaud A; Martin A; Berille J; Ganz PA; Partridge AH; Delaloge S; Michiels S; Andre F; Vaz-Luis I
Ann Oncol; 2019 Nov; 30(11):1784-1795. PubMed ID: 31591636
[TBL] [Abstract][Full Text] [Related]
20. Population-based study of the relationship of treatment and sociodemographics on quality of life for early stage breast cancer.
Janz NK; Mujahid M; Lantz PM; Fagerlin A; Salem B; Morrow M; Deapen D; Katz SJ
Qual Life Res; 2005 Aug; 14(6):1467-79. PubMed ID: 16110927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
